Glutathione S-transferase mu 1 (GSTM1): Breast cancer susceptibility gene;Glutathion S-transferase mu 1 (GSTM1): Gene de susceptibilite du cancer du sein

Bulletin du Cancer

Volumn 84, Issue 1, 1997, Pages 35-40

  Fontana, Xavier ^a   Peyrotte, Isabelle ^a   Valente, Eliane ^a   Rossi, Charlie ^a   Ettore, Francette ^a   Namer, Moïse ^a   Bussière, Françoise ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

breast cancer; glutathione S transferase mu 1; susceptibility

Indexed keywords

CATHEPSIN D; GLUTATHIONE TRANSFERASE; DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; TUMOR SUPPRESSOR GENE; AGE; BREAST TUMOR; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REVIEW;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0030625857     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Alexandrie AK, Sundberg MI, Seidegard J, et al. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1 : a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994; 15: 1785-90.
2. Ambrosone CB, Freudenheim JL, Graham S, et al. Cytochrome P4501A1 and glutathione (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995; 55: 3483-5.
3. Anttila S, Hirvonen A, Husgafvel-Pursiainen K, et al. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994; 15: 1133-5.
4. Band V, Zagetowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 1990; 87: 463-7.
5. Bell DA, Thompson CL, Taylor J, et al. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase μ. Environmental Health Perspectives 1992; 98: 113-7.
6. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited effect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-64.
7. e Journées nationales de la Société française de sénologie et de pathologie mammaire, pathologie du sein de la femme jeune. Centre Jean-Perrin Clermont-Ferrand 1994: 191-8.
8. Brockmöller J, Kerb R, Drakouli N, et al. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and φ in lung cancer patients and controls. Cancer Res 1993; 53: 1004-11.
9. Brockmöller J, Kerb R, Drakoulis N, et al. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994; 54: 4103-11.
10. Chenevix-Trench G, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995; 16: 1655-7.
11. Devilee P, Cornelisse CJ. Genetics of human breast cancer. Cancer Survey 1990; 9: 605-30.
12. Easton D, Ford D, Peto J. Inherited susceptibility to breast cancer. Cancer Surveys : Breast Cancer 1993; 18: 95-113.
13. Fantl V, Smith R, Brookes S, et al. Chromosome 11 q13 abnormalities in human breast cancer. Cancer Surveys: Breast Cancer 1993; 18: 77-94.
14. Fields WR, Li Y, Townsend AJ. Protection by transfected glutathione S-transferase isozymes against carcinogen-induced akylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis 1994; 15: 1155-60.
15. Fontana X, Ferrari P, Milano G, et al. Analysis of c-myc amplification by the differential polymerase chain reaction d-PCR, study in breast cancer. Oncology Report 1994a; 1: 361-6.
16. Fontana X, Ferrari P, Abbes M, et al. Étude de l'amplification du gène mdm2 dans les tumeurs primitives du cancer du sein. Bull Cancer 1994b; 81: 587-92.
17. Franceschi S, la Vecchia C, Negri E, et al. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781-5.
18. Garcia I, Brandt D, Weintraub J, et al. Loss of heterozygosity for the short arm of chromosome 11 11p15 in human milk epithelial cells immortalized by microinjection of SV 40 DNA. Cancer Res 1991; 51: 294-300.
19. Gray GE, Pike MC, Henderson BE. Breast cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices. Br J Cancer 1979; 39: 1-7.
20. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine 1993; 329: 1318-27.
21. Howe GR, Friedenreich CM, Jain M, Miller AB. A cohort study of fat intake and risk of breast cancer. J Natl Cancer Inst 1991; 83: 336-40.
22. Howie AF, Miller WR, Hawkins RA, et al. Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer 1989; 60: 834-7.
23. Hruza C, Dobianer K, Beck A, et al. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. Eur J Cancer 1993; 29A: 1593-7.
24. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiologic Reviews 1993; 15: 110-32.
25. Hunter DJ, Willett WC. Diet, body build, and breast cancer. Ann Rev Nutr 1994; 14: 393-418.
26. Katoh A, Watzlaf VJM, D'Amico F. An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 1994; 70: 928-33.
27. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 1994; 15: 415-8.
28. Kihara M, Noda K, Kihara M. Distribution of GSTM1 null genotype in re ation to gender, age and smoking status in Japanese lung cancer patients. Pharmacogenetics 1995; 5: S74-9.
29. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993; 269: 1975-80.
30. Lees AW, Jenkins HJ, May CL, et al. Risk factors and 10-year breast cancer survival in Northern Alberta. Breast Cancer Res Treat 1989; 13: 143-51.
31. Liu YH, Taylor J, Linko P, et al. Glutathione S-transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis 1991; 12: 2269-75.
32. Lynch HT, Albano WA, Heieck JJ. Genetics, biomarkers and control of breast cancer: a review. Cancer Genet Cytogenet 1984; 13: 43-92.
33. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54: 1969-75.
34. Molina R, Oesterreich S, Zhou JL, et al. Glutathione transferase GST pi in breast tumors evaluated by three techniques. Disease markers 1993; 11: 71-82.
35. Morrow M. Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat 1994; 31: 53-60.
36. Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17 q12-q23. Lancet 1991; 338: 82-3.
37. Neubauer A, Neubauer B, He M, Effert P, et al. Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 1992; 7: 1019-25.
38. Noller KL, Fish CR. Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am 1974; 58: 793-810.
39. Risinger JI, Terry LA, Boyd J. Use of representational difference analysis for the identification of mdm2 oncogene amplification in diethylstilbestrol-induced murine uterine adenocarcinomas. Molecular Carcinogenesis 1994; 11: 13-8.
40. Ross VL, Board PG, Webb GC. Chromosomal mapping of the human mu class glutathione S-transferases to 1 p13. Genomics 1993; 18: 87-91.
41. Russo J, Calaf G, Sohi N, et al. Critical steps in breast carcinogenesis. Breast cancer: from biology to therapy. Ann N Y Acad Sci 1993; 698: 1-20.
42. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A Laboratory Manual. 2nd edition, New York: Cold Spring Harbor Laboratory Press, 1989.
43. Schatzkin A, Palmer JR, Rosenberg L, et al. Risk factors for breast cancer in black women. J Nat Cancer Inst 1987; 78: 213-7.
44. Shea TC, Claflin G, Comstock KE. Glutathione fransferase activity and isoenzyme composition in primary human breast cancers. Cancer Res 1990; 50: 6848-53.
45. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. JAMA 1993; 270: 1563-8.
46. Smith HS, Lu Y, Deng G, et al. Molecular aspects of early stages of breast cancer progression. J Cell Biochem 1993; 17G: 144-52.
47. Swift M, Morrel D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 3325: 1831-6.
48. The Merck Index: an encyclopedia of chemicals, drugs and biologicals. Eleventh edition Merck and Co, Inc Rahway N J USA, 1989.
49. Thorpe SM, Rochefort H, Garcia M, et al. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 1989; 49: 6008-14.
50. Van de Vijver MJ, Nusse R. The molecular biology of breast cancer. Biochim et Biophys Acta 1991; 1072: 33-50.
51. Vatten LJ, Kvinnsland S. Body height and risk of breast cancer A prospective study of 23,831 Norwegian women. Br J Cancer 1990; 61: 881-5.
52. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA Jr. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 1990; 50: 1585-90.
53. Willett WC. Micronutrients and cancer risk. Am J Clin Nutr 1994; 59: 1162-5.
54. Wynder EL, Cohen LA, Rose DP, Stellman SD. Dietary fat and breast cancer: where do we stand on the evidence? J Clin Epidemiol 1994; 47: 217-22.
55. Yuen J, Ekbom A, Trichopoulos D, et al. Season of birth and breast cancer risk in Swenden. Br J Cancer 1994; 70: 564-8.
56. Zhong S, Wyllie AH, Barnes D, et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14: 1821-4.